Home

Katherine Stueland, CEO: GeneDx Holdings WGS Sell · Filed 02/02

Trade details

Type
Insider sale
Amount
$155,382
Shares · price
1,653 sh · $94.00 a share
Held after
16,458 sh
Trade date
26/01/29
Filed
26/02/02
Days to filing
4 days

Sold 9.1% of holdings

Share of holding sold
9.1%

GeneDx Holdings trades, last 26 weeks

What else happened in GeneDx Holdings around then

Filed or reported within 30 days of the trade day · 25/12/30~02/28

Katherine Stueland's recent trades

  • Katherine Stueland

    Planned saleGeneDx Holdings

    $1.2M

    Filed 09/01

  • Katherine Stueland

    SellGeneDx Holdings

    $360.8K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $149.4K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $127.9K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $195.7K

    Filed 06/11